Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis

Xingchen Wu, Lars Grüner Hanson, Arnold Skimminge, Per Soelberg Sorensen, Olaf Bjarne Paulson, Henrik Kahr Mathiesen, Morten Blinkenberg

6 Citationer (Scopus)

Abstract

Objective: To evaluate the prognostic value of the cortical N-acetyl aspartate to creatine ratio (NAA/Cr) in early relapsing-remitting multiple sclerosis (RRMS). Methods: Sixteen patients with newly diagnosed RRMS were studied by serial MRI and MR spectroscopic imaging (MRSI) once every 6 months for 24 months. Clinical examinations, including the expanded disability status scale (EDSS), were performed at baseline, month 24, and at year 7. Results: Baseline cortical NAA/Cr correlated inversely with EDSS at month 24 (r = -0.61, P<0.05), and patients with EDSS ≥ 4 had a lower baseline cortical NAA/Cr compared to those with EDSS less than 4 (P<0.05). Baseline cortical NAA/Cr also correlated inversely with EDSS at the 7-year follow-up (r = -0.56, P<0.05), and patients with EDSS ≥ 4 had a lower baseline cortical NAA/Cr compared to those with EDSS less than 4 (P< 0.05). Baseline brain parenchymal fraction (BPF) correlated inversely with EDSS at month 24 (r = -0.61, P<0.05), but not with EDSS at year 7. Discussion: Cortical NAA/Cr in early RRMS correlated with clinical disability after 2 and 7 years and may be used as a predictor of long-term disease outcome.

OriginalsprogEngelsk
TidsskriftNeurological Research
Vol/bind36
Udgave nummer8
Sider (fra-til)701-708
Antal sider8
ISSN0161-6412
DOI
StatusUdgivet - aug. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis'. Sammen danner de et unikt fingeraftryk.

Citationsformater